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Abstract 
Infectious Bursal Disease (IBD) is one of the oldest and widely known poultry diseases all over 
the world. It is caused by IBD virus of Avibirnavirus genus of family Birnaviridae family. IBD has 
great economical impact on backyard poultry world as it causes high weakness and mortality. 
The objective of present study was to evaluate the antibody response in village chickens in 
India after vaccinating them with IBD live vaccine. Serum was collected at regular intervals 
from chickens up to 112 days after vaccination. Antibodies against IBD virus were measured 
using ELISA method. It was observed that the vaccines with both intermediate and 
intermediate invasive strain caused good immune response in the birds. Serum antibody level 
was found significantly high in 28 days blood collection, which decreased gradually up to 112 
days. It was also observed that Intermediate invasive strain produced higher amount of 
antibodies than intermediate strain of the vaccine. Furthermore, it is also suggested that good 
diet and biosecurity measures in backyard chickens and proper vaccination program can 
benefit the local farmers of Asian countries. 
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INTRODUCTION 
Infectious Bursal Disease (IBD) is an important disease 
of poultry, which occurs due to infection of IBD virus of 
Avibirnavirus genus of Birnaviridae family. It is a fatal 
disease and causes high and rapid mortality in young 
chickens leading to significant economic loss. It is a highly 
contagious viral disease, which is characterized by 
destruction of lymphoid organs, particularly bursa of 
fabricius, where B lymphocytes mature and differentiate. 
The disease was first reported by Cosgrove (1962). 
Several outbreaks have been reported in many countries 
like USA, Europe, Africa, Far East, Asia and Australia 
(Hailu et al., 2009, Khan et al., 2009, Lasher & Davis, 1997; 
Faragher, 1972; Firth, 1974; Jones, 1986; Lasher & Shane, 
1994; Muller et al., 2012, Oluwayelu et al. 2014, Provost et 
al., 1972; Van Den Berg, 2000; Van Der Sluis, 1999). IBD 
has incubation period of two to three days (Kegne and 
Chanie, 2014; Dorji et al., 2016; Lawal et al., 2016, Li et al., 
2018). It causes mortality up to 50 to 60% in laying hens 
and 25 to 30% in broilers. The hypervirulent strain of virus 
causes 100% mortality in specific pathogen free chickens 
(Nunoya et al., 1992, Van Den Berg et al., 1991). The 
symptoms of the disease include exhaustion, prostration, 
dehydration, diarrhoea and ruffled feathers. The mortality 
starts within third day of infection, reaches to peak within 
four days and sickness of birds persist for up to seven 
days. The severity of disease may vary with age and breed 
of birds, virulence of the strain and degree of passive 
immunity (Van Den Berg et al., 2000). The principal organ 
affected is bursa of fabricious, additionally, other lymphoid 
organs are also affected. The virus targets B lymphocyte 
cells in active division stage (Kaufer & Weiss, 1980; 
Sharma et al., 1993; Tanimura et al., 1995). Apparent 
macroscopic inflammation can be observed in  infected 
bursa (McFerran, 1993). 
The disease causes high financial losses as it causes 
high mortality, secondary infections, growth retardation and 
carcasses have to be discarded due to haemorrhages. IBD 
is also found prevalent in village chicken in various 
countries, where backyard poultry is a significant part of 
poultry business (Wilcox et al., 1983; Swai et al., 2011; 
Sule et al., 2013; Yuguda et al., 2014, Bettridge et al., 
2014). In India, 11% egg production is contributed by 
village chickens (Kumaresan et al., 2008). Economically, 
rearing and egg production is a vital part of poultry 
business in villages of Asian and African countries (Gueye, 
2000). Vaccination is the principal method to control IBD 
(Muller et al., 2012). Generally IBD is controlled by 
vaccination of the flock and the infected birds are culled to 
prevent the spread of the disease. For proper vaccination 
of birds with IBD vaccine, strict schedule of vaccination has 
to be followed. Proper guidelines of poultry farming, 
sanitation, cleaning, feeding and water supply need to be 
observed. The vaccine should be selected based on user-
easiness, economy, availability, immunogenicity and 
transportation facility. In countries like Africa and India, 
people are having village chickens in small numbers. With 
this background, this study was designed to estimate 
seroconversion of IBD live vaccine in improving protection 
from IBD in backyard chickens. 
  
MATERIALS AND METHODS 
Grouping and rearing of birds  
The study was conducted in two villages of Gujarat 
state – Merda Adraj and Jetpura. The birds were reared by 
local farmers with free access to feed and water. The 
chickens were monitored daily for any clinical signs and 
symptoms until the study completed. 
Total 90 Kadaknath backyard birds, 14 day old, were 
divided in three groups with 30 birds in each group:  
Group 1: Treated with intermediate strain Gumboro live 
vaccine (procured from Hester Biosciences Limited, India) 
Group 2: Treated with intermediate invasive strain 
Gumboro live vaccine (procured from Hester Biosciences 
Limited, India) 
Group 3: Control group, untreated 
 
Experimental procedure 
Vaccines were administered intraoccular with single 
dose of Gumboro live vaccine vaccine (Intermediate strain) 
and Gumboro live vaccine (Intermediate Invasive strain) 
respectively, with EID50 not less than 1 x 10
3 
/dose, 
procured from Hester Biosciences Limited, India. From 0 to 
112 days of vaccination, blood was withdrawn from birds. 
After 24 hours, serum was separated and stored at -20 °C 
until testing. 
All sera samples were subjected to indirect ELISA test 
using ELISA kit (IDEXX laboratories, USA) at Hester 
Biosciences Limited, Anand laboratory. The ELISA test 
was performed as per the manufacturer's protocol and 
instructions. Before use, all the samples and reagents were 
allowed to room temperature and homogenized by gentle 
mixing.  All the samples were diluted at 1:500 with sample 
diluents provided by the manufacturer. The antibody used 
in the study was serum and it is specific to chickens. 100 µl 
of two negative control samples were added. One was 
added to well A1 and another was added to B1. 100 µl of 
two positive control samples were added. One was added 
to well C1  and another was added to well D1. Both positive 
and negative controls were provided by IDEXX 
laboratories, USA. Then 100 µl of diluted samples were 
added into the appropriate wells and incubated at 25 C for 
30 minutes by covering the plate with lid. After that, content 
of the well was emptied and washed 3 to 5             
                                                         
                                                         
                                                          
minutes. Following washing for 3 to 5 times with sterile 
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distilled wat                                          
                                                        
                                                         
stop solution was added to the each well to stop the 
reaction. The stop solution contained sulphuric acid. Then 
the microtitre ELISA plate was placed in the ELISA reader 
(Biotek ELX 800, USA) and the intensity of the color 
produced from the ELISA test was measured 
photometrically at 650 nm wavelength.  
 
Data analysis 
Simple t test were used for statistical analysis of the 
obtained data using IBM SPSS 20 software (please add 
version number, state and country). P < 0.05 was 
considered statistically significant. 
 
RESULTS 
Samples from all groups were collected and test was 
performed using ELISA kit. Pre-vaccination titres of all 
groups were measured i.e., group 1, 2 and 3 were 8.0 ± 
0.8, 51.73 ± 22.0 and 8.9 ± 0.9 respectively. The ELISA 
titre increased after vaccination and at 28 days, it reached 
to highest value post vaccination (3978.8 ± 251.1 in group 
1 and 4637.6 ± 185.4 in group 2). As after 28 days, titre 
decreased and was found to be 504.8 ± 19.5 and 1042.3 ± 
189.0 in group 1 and 2 respectively at 112 days. The data 
of 28 days and 0 days results were compared and same of 
28 days and 112 days were compared and significant 
difference was found (p< 0.05, Figure 1 and 2). Titre of 
control group was found to be 7.2 ± 0.6 to 15.7 ± 3.5 
throughout the study (Figure 3). The titre greater than 396 
is considered as positive, hence values below it are 
considered negligible statistically. 
 
 
 
Fig. 1. ELISA titre of group 1 (Vaccinated with IBD live 
vaccine intermediate strain). 
The results are mentioned as mean ± SEM 
* data are significantly different from that of 0 days 
# data are significantly different from that of 28 days 
 
 
 
Fig. 2. ELISA titre of group 2 (Vaccinated with IBD live 
vaccine intermediate Invasive strain). 
The results are mentioned as mean ± SEM 
* Data are significantly different from that of 0 days 
# Data are significantly different from that of 28 days 
 
 
 
 
Fig. 3. Post vaccination titre of group 3 (Control) 
The results are mentioned as mean ± SEM 
 
DISCUSSION 
ELISA has been considered as an accurate and 
preferable method for detection of specific antibodies 
against both intermediate and intermediate invasive strains 
of IBD (Marquardt et al., 1980; Meulemans et al., 1987). 
The ELISA titre of 396 is considered positive for antibodies 
against IBD virus as per the guidelines of manufacturer of 
ELISA kit. Seroprevalence of IBD is commonly found in 
many parts of world (Sule et al., 2013; Wilcox et al., 1983; 
Yuguda et al., 2014). It can be found from 0 day titre that 
the birds were not having infection of Gumboro disease at 
time of collection. The ELISA titre of vaccinated birds 
increased to protective amount within 7 days post 
vaccination as reported by Moraes et al., (2004); Jakka et 
al., (2014) and Otsyina et al., (2009). The level of titre 
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attained protective level against the disease significantly 
(p<0.05) after 28 days of vaccination in both the vaccinated 
group. Jakka et al., (2014) and Moraes et al., (2004) 
reported that Intermediate invasive strain produces higher 
level of defence against the disease as compared to 
Intermediate strain vaccine. Similar results were reported in 
present study at 28 days of collection, where both vaccines 
produced maximum level of protection, but statistically 
there was no significant difference found in the 28 days titre 
between intermediate and intermediate invasive strain 
groups. Zaheer et al., 2003 reported satisfactory immune 
response against commercial IBD vaccine up to 42 days 
post vaccination. In present study with extended period of 
serum collection, it was observed that up to 112 days, the 
titre was protective and can provide protection against the 
disease up to 16 weeks. The vaccine should be repeated 
to provide much higher protection after 16 weeks.                                                       
 
CONCLUSION 
As IBD is the oldest disease of poultry and great 
challenge to the poultry farming, it is necessary to protect 
the flocks from the disease with help of proper biosecurity 
measures and effective vaccination program against 
Gumboro disease. It can be concluded from present study 
that vaccination of flocks at younger age with any of the two 
strains can protect the chicks from the disease. This will 
help the farmers to boost the productivity and economy of 
the industry. 
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